Clinical Trial

Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients

Name: Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients — clinical trial record (NCT07697833)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: VERICIGUAT

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

To compare the effectiveness and safety of Vericiguat with Standard Medical Treatment in Patients with Heart Failure and Reduced Ejection Fraction

Trial Details

NCT Number	NCT07697833
Lead Sponsor	National Institute of Cardiovascular Diseases, Pakistan Collaborators: Horizon Pharmaceuticals
Conditions	Heart Failure With Reduced Ejection Fraction (HFrEF)
Enrollment	500 participants
Start Date	2026-07-15
Primary Completion	2027-05-15 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-13